{"session_id": 61, "bill_id": 21670, "bill_type": "Senate Bill", "bill_number": 211, "bill_title": "prohibit the interchange of anti-epileptic drugs without prior notification and consent.", "sponsors": [{"legislator_profile_id": 3618, "is_prime": true}, {"legislator_profile_id": 3653, "is_prime": true}, {"legislator_profile_id": 3571, "is_prime": false}, {"legislator_profile_id": 3576, "is_prime": false}, {"legislator_profile_id": 3578, "is_prime": false}, {"legislator_profile_id": 3580, "is_prime": false}, {"legislator_profile_id": 3581, "is_prime": false}, {"legislator_profile_id": 3586, "is_prime": false}, {"legislator_profile_id": 3587, "is_prime": false}, {"legislator_profile_id": 3593, "is_prime": false}, {"legislator_profile_id": 3596, "is_prime": false}, {"legislator_profile_id": 3602, "is_prime": false}, {"legislator_profile_id": 3604, "is_prime": false}, {"legislator_profile_id": 3605, "is_prime": false}, {"legislator_profile_id": 3607, "is_prime": false}, {"legislator_profile_id": 3608, "is_prime": false}, {"legislator_profile_id": 3609, "is_prime": false}, {"legislator_profile_id": 3611, "is_prime": false}, {"legislator_profile_id": 3617, "is_prime": false}, {"legislator_profile_id": 3621, "is_prime": false}, {"legislator_profile_id": 3626, "is_prime": false}, {"legislator_profile_id": 3627, "is_prime": false}, {"legislator_profile_id": 3630, "is_prime": false}, {"legislator_profile_id": 3633, "is_prime": false}, {"legislator_profile_id": 3634, "is_prime": false}, {"legislator_profile_id": 3636, "is_prime": false}, {"legislator_profile_id": 3637, "is_prime": false}, {"legislator_profile_id": 3638, "is_prime": false}, {"legislator_profile_id": 3641, "is_prime": false}, {"legislator_profile_id": 3642, "is_prime": false}, {"legislator_profile_id": 3644, "is_prime": false}, {"legislator_profile_id": 3645, "is_prime": false}, {"legislator_profile_id": 3647, "is_prime": false}, {"legislator_profile_id": 3650, "is_prime": false}, {"legislator_profile_id": 3652, "is_prime": false}, {"legislator_profile_id": 3656, "is_prime": false}, {"legislator_profile_id": 3657, "is_prime": false}, {"legislator_profile_id": 3658, "is_prime": false}, {"legislator_profile_id": 3661, "is_prime": false}, {"legislator_profile_id": 3664, "is_prime": false}, {"legislator_profile_id": 3668, "is_prime": false}, {"legislator_profile_id": 3670, "is_prime": false}, {"legislator_profile_id": 3672, "is_prime": false}, {"legislator_profile_id": 3673, "is_prime": false}, {"legislator_profile_id": 3675, "is_prime": false}, {"legislator_profile_id": 3676, "is_prime": false}], "keywords": ["Professional and Occupational Licensing", "Public Safety"], "audio": [{"meeting_datetime": "2007-02-05T00:00:00-06:00", "committee": "SHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2007/she19.mp3", "start_seconds": 153.0}, {"meeting_datetime": "2007-02-05T00:00:00-06:00", "committee": "SHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2007/she19.mp3", "start_seconds": 153.0}, {"meeting_datetime": "2007-02-05T00:00:00-06:00", "committee": "SHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2007/she19.mp3", "start_seconds": 153.0}, {"meeting_datetime": "2007-02-05T00:00:00-06:00", "committee": "SHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2007/she19.mp3", "start_seconds": 153.0}], "bill_versions": [{"bill_id": 21670, "bill_version_id": 111244, "bill_version": "Introduced", "bill_version_date": "2007-01-31T10:18:02-06:00", "bill_text": "FOR AN ACT ENTITLED, An Act to prohibit the interchange of anti-epileptic drugs without prior notification and consent. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF SOUTH DAKOTA: Section 1. That chapter 36-11 be amended by adding thereto a NEW SECTION to read as follows: No pharmacist may interchange an anti-epileptic drug for the treatment of seizures without prior notification of, and the documented informed consent of, such interchange from the prescribing physician and the patient, or the patient's parent, legal guardian, or spouse. For the purposes of this section, an anti-epileptic drug is any drug prescribed for the treatment of epilepsy or any drug used to treat or prevent seizures. For the purposes of this section, an interchange is the substitution of one version of the same anti-epileptic therapeutic product, including a generic version for the prescribed brand, a brand version for the prescribed generic version, a generic version by one manufacturer for a generic version by a different manufacturer, a different formulation of the prescribed anti-epileptic drug, or a different anti-epileptic therapeutic drug product for the anti-epileptic product originally prescribed."}], "amendments": [], "fiscal_notes": [], "action_log": [{"bill_id": 21670, "action_date": "2007-01-31T14:00:00-06:00", "document_id": 111295, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/111295.pdf", "status_text": "First read in Senate and referred to", "journal_page": 311, "committee_id_action": 924, "committee_id_assigned": 901, "result": "N", "vote": {}}, {"bill_id": 21670, "action_date": "2007-02-05T10:00:00-06:00", "document_id": 111541, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/111541.pdf", "status_text": "Scheduled for Committee hearing on this date", "journal_page": null, "committee_id_action": 901, "committee_id_assigned": null, "result": "N", "vote": {}}, {"bill_id": 21670, "action_date": "2007-02-05T10:00:00-06:00", "document_id": 111541, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/111541.pdf", "status_text": "Deferred to 41st legislative day", "journal_page": 373, "committee_id_action": 901, "committee_id_assigned": null, "result": "P", "vote": {"vote_id": 66795, "president_vote": null, "Yea": [3595, 3607, 3647, 3669, 3585], "Nay": [3621, 3623]}}]}